Given the many targets of IFNγ, TNFα, and IL-1β, their prominent roles in cell-cell communication within the CNS, and variations in their expression over the course of acute and chronic neuroinflammatory disease, these cytokines remain relevant targets of MS research. Here, IL1B is linked to myeloid sarcoma.